@WHO: 💊 Nirmatrelvir/ritonavir should be given within 5⃣ days of #COVID19 symptom onset; therefore, increasing access to testing & diagnosis is essential. https://t.co/ItNygISp5V

http://twitter.com/WHO
via IFTTT